RaySearch Establishes Sales and Support Company in Germany

RaySearch has established a German subsidiary, RaySearch Germany GmbH. The new subsidiary is fully responsible for the marketing, sales and service of RaySearch’s proprietary treatment planning system RayStation® in Germany, Austria and the German-speaking parts of Switzerland. It will serve new as well as existing customers such as DKFZ and WPE in Germany and MedAustron in Austria.

The German subsidiary is led by Mr. Radu Pintea. Mr. Pintea is a trained medical physicist and brings over 20 years' experience from the radiation therapy industry and has held senior sales positions primarily in treatment planning but also in medical equipment and accessories for radiotherapy.

"I am very happy to join RaySearch in this exciting phase. RayStation® is clearly the leading treatment planning system on the market with unique features such as multi-criteria optimization and full support for adaptive therapy and proton therapy. I am off to a flying start and look forward to working with new and existing customers in the region. We will participate as an exhibitor at all the important trade shows in 2014 starting with DEGRO in Düsseldorf," says Radu Pintea, Business Director of RaySearch Germany GmbH.

Johan Löf, CEO of RaySearch, comments: "We have been active in Germany for almost five years since WPE in Essen became the very first RayStation® customer in 2009. Over the years we have supported the German-speaking market from Stockholm. As we now see an increasing demand from the region it is time to increase our presence and I am very happy to welcome Radu Pintea to RaySearch. With his extensive experience he will be instrumental to expand and support our growing customer base in the region."

About RayStation®
RayStation® integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron and proton therapy. The system is built on the latest software architecture and has a graphical user interface offering state-of-the-art usability.

About RaySearch
RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch’s products are mainly sold through license agreements with leading partners such as Philips, Nucletron, IBA, Varian and Brainlab. To date, 15 products have been launched through partners and RaySearch’s software is used at 2,500 clinics in more than 65 countries. In addition, RaySearch offers the proprietary treatment planning system RayStation® directly to clinics. RaySearch was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and the company is listed in the Small Cap segment on NASDAQ OMX Stockholm.

Most Popular Now

European Artificial Intelligence Act Com…

The European Artificial Intelligence Act (AI Act), the world's first comprehensive regulation on artificial intelligence, enters into force. The AI Act is designed to ensure that AI developed and used...

Patient Safety must be Central to the De…

An EPR system brings together different patient information in one place, making it easier to access for healthcare professionals. This information can include patients' own notes, test results, observations by...

ChatGPT Shows Promise in Answering Patie…

The groundbreaking ChatGPT chatbot shows potential as a time-saving tool for responding to patient questions sent to the urologist's office, suggests a study in the September issue of Urology Practice®...

Survey: Most Americans Comfortable with …

Artificial intelligence (AI) is all around us - from smart home devices to entertainment and social media algorithms. But is AI okay in healthcare? A new national survey commissioned by...

AI can Help Rule out Abnormal Pathology …

A commercial artificial intelligence (AI) tool used off-label was effective at excluding pathology and had equal or lower rates of critical misses on chest X-ray than radiologists, according to a...

AI Spots Cancer and Viral Infections at …

Researchers at the Centre for Genomic Regulation (CRG), the University of the Basque Country (UPV/EHU), Donostia International Physics Center (DIPC) and the Fundación Biofisica Bizkaia (FBB, located in Biofisika Institute)...

Video Gaming Improves Mental Well-Being

A pioneering study titled "Causal effect of video gaming on mental well-being in Japan 2020-2022," published in Nature Human Behaviour, has conducted the most comprehensive investigation to date on the...

New Diabetes Research Links Blood Glucos…

As part of its ongoing exploration of vocal biomarkers and the role they can play in enhancing health outcomes, Klick Labs published a new study in Scientific Reports - confirming...

Machine learning helps identify rheumato…

A machine-learning tool created by Weill Cornell Medicine and Hospital for Special Surgery (HSS) investigators can help distinguish subtypes of rheumatoid arthritis (RA), which may help scientists find ways to...

New AI Software could Make Diagnosing De…

Although Alzheimer's is the most common cause of dementia - a catchall term for cognitive deficits that impact daily living, like the loss of memory or language - it's not...

A New AI Tool for Cancer

Scientists at Harvard Medical School have designed a versatile, ChatGPT-like AI model capable of performing an array of diagnostic tasks across multiple forms of cancers. The new AI system, described Sept...

Vision-Based ChatGPT Shows Deficits Inte…

Researchers evaluating the performance of ChatGPT-4 Vision found that the model performed well on text-based radiology exam questions but struggled to answer image-related questions accurately. The study's results were published...